Search results
Research finds negativity about vaccines surged on Twitter after COVID-19 shots became available
Medical Xpress· 2 weeks agoThere was a marked increase in negativity about vaccines on Twitter after COVID-19 vaccines became...
ESCMID 2024: Cutting-edge vaccines in development for a healthier tomorrow
Clinical Trials Arena via Yahoo Finance· 1 week agoThe session consisted of speakers showcasing breakthroughs in vaccine development across a variety...
ESCMID 2024: Highlights on prophylaxis and treatment of infectious diseases
Clinical Trials Arena via Yahoo Finance· 1 week agoFollowing a near 60-year technological gap, two vaccines for the prevention of respiratory syncytial...
Merck reports promising V116 vaccine trial results By Investing.com
Investing.com· 2 weeks agoThe findings, announced at the European Society of Clinical Microbiology and Infectious Diseases...
Pandemic fatigue and vaccine hesitancy continue to affect global public health, new 23-country study...
Medical Xpress· 2 weeks agoSPH). "The repercussions of pandemic disruptions in health care services, the effects of the...
Merck Announces Positive Data for V116, an Investigational, 21-Valent Pneumococcal Conjugate Vaccine...
Morningstar· 2 weeks agoThe trial evaluated the immunogenicity, tolerability and safety of V116 compared to PPSV23 (pneumococcal vaccine, polyvalent [23-valent]) in adults 50 years of age and older ...
Cervical cancer vaccine roll-out shows efficacy in reducing cervical cancer and other HPV-related...
Medical Xpress· 2 weeks agoWith the creation of safe and efficacious vaccines to target human papillomavirus in the first...
NIH Reports Lower Dose of Mpox Vaccine is Safe and Generates Six-Week Antibody Response Equivalent...
Sierra Sun Times· 2 weeks agoThe results suggest that antibody responses contributed to the effectiveness of dose-sparing mpox ...
On doorstep of approval, Merck compares V116 pneumococcal vaccine to 1983 warhorse Pneumovax 23
FierceBiotech· 2 weeks agoFive months ago, Merck revealed data that indicate its next-generation pneumococcal vaccine offers more protection for older adults than Pfizer’s market dominator Prevnar ...
The man with the longest-lasting COVID-19 infection: Case study
Becker’s Hospital Review· 1 week agoThe person with the longest consecutive COVID-19 infection was a 72-year-old man in Amsterdam who was documented to have the infection for 612 days, Scientific American reported May 1. The man ...